Noelia Nebot

Noelia Nebot is the Vice President of Business Development for Asia at C2i Genomics. Noelia has over ten years of experience in the pharmaceutical industry, specializing in clinical pharmacology and population PK-PD modeling.

Noelia started their career as a Pharmacokinetics and Pharmacodynamic Fellow at the University of North Carolina at Chapel Hill. Noelia then went on to work as a Clinical Pharmacology Manager at GlaxoSmithKline, where they were involved in model-based drug development projects with a focus on decision analysis. In 2015, they joined Novartis Oncology as an Associate Director (Senior Investigator II) of Clinical Pharmacology. While at Novartis, they supported Clin Pharm Studies as a Pharmacokineticist and developed Population PK-PD models with a focus on new targeted agents for oncology.

In 2020, Noelia left Novartis to join C2i Genomics as the Vice President of Business Development for Asia. In this role, they are responsible for identifying and developing new business opportunities in Asia and expanding the company’s presence in the region.

Noelia Nebot received their PhD in In vitro metabolism imatinib from the University of Sydney. Noelia also holds an Honours degree in signal transduction pathways CYP2J2 from the same school. Nebot started their educational career with a Bachelor's degree in Bioinformatics from the University of Sydney. Noelia has also received certification from WOBI in Personal leadership and organizational culture.

Noelia Nebot reports to Mark Oldroyd, CBO. They are on a team with and Casey Frankenberger - VP, Business Development, Americas.